COMP <GO>
MC vs BRK-B // EV/EBITDA & P/E VALUATION
Moelis & Company (NYSE) VS. Berkshire Hathaway Inc. (NYSE) • 15-METRIC TALLY: MC 7
— BRK-B 6
▲ EV/EBITDA & P/E VALUATION LEADER: BRK-B
LAST: $58.59 (-2.32%) • MKT CAP: $4.69B
valuation
15.2x
LAST: $542.49 (+0.10%) • MKT CAP: $1.16T
valuation
9.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MC VS. BRK-B)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MC | BRK-B | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 42.80% | 11.47% | +31.33 | MC | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 15.2x | 9.7x | +5.52 | BRK-B | /valuation <GO> |
| Free Cash Flow Yield | 11.50% | 2.09% | +9.41 | MC | /fcf-yield <GO> |
| Operating Margin | 20.80% | 27.80% | -7.00 | BRK-B | /operating-margins <GO> |
| Net Profit Margin | 19.80% | 22.30% | -2.50 | BRK-B | /net-margins <GO> |
| Revenue Growth (YoY) | 23.10% | 3.93% | +19.17 | MC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.50 | 2.85 | +0.65 | MC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 4/9 | +5.00 | MC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 3.55% | +2.95 | BRK-B | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.7 | 66.8 | -12.13 | BRK-B | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.88 | 0.61 | +0.27 | MC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.2x | 24.3x | -9.14 | MC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.69B | $1.16T | -$1.16T | BRK-B | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MC REV | BRK-B REV | MC GROSS % | BRK-B GROSS % | MC FCF | BRK-B FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $371.44B | — | — | $540.0M | $25.04B |
| FY 2024 | $0 | $371.43B | — | — | $415.4M | $11.62B |
| FY 2023 | $0 | $364.48B | — | — | $158.5M | $29.79B |
| FY 2022 | — | $302.02B | — | — | — | $21.89B |
| FY 2021 | — | $276.19B | — | — | — | $26.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MC // BETA 0.88
BRK-B // BETA 0.61